SPI Generative AI: A Provider’s Place in the Data Debate

Published: February 13, 2024

This Insight is part of Signify Research’s Signify Premium Insights – Generative AI service. This content is only available to subscribers. To become a subscriber, or to register for a complimentary trial of the service, please follow the link below.

Since leaping to the front of widespread consciousness in 2022, the conversation about generative AI has been dominated by a handful of the nascent technology’s biggest players. OpenAI got the ball rolling when it released ChatGPT, with Microsoft’s investments into the company and adoption of OpenAI’s tools into its products bringing that vendor into the mix, while Google, Amazon and even Meta have also generated excitement with their own tools and focuses.

Recently, however, others have been entering the fray. Some of these new enthusiasts are not tech firms, are not even healthcare technology vendors, but several providers have now begun working on the technology. NYU Langone, for example, has used unstructured clinical notes to train its own LLM.

Providers have the clinical expertise, but do they also have a place at the forefront of technology? Or are foundation models best left to the tech giants?

The Signify View

Fundamentally, the success of a foundation model is determined by just three separate factors.